These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6186865)

  • 1. Blockade of dopamine receptors in the renal vasculature by isomers of flupenthixol and sulpiride.
    Schmidt M; Imbs JL; Giesen EM; Schwartz J
    J Cardiovasc Pharmacol; 1983; 5(1):86-9. PubMed ID: 6186865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of SK&F 82526 and SK&F 83742 on the renal vascular dopamine receptor.
    Schmidt M; Imbs JL; Giesen-Crouse EM; Schwartz J
    J Pharmacol; 1985; 16(1):15-22. PubMed ID: 2582206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney.
    Schmidt M; Krieger JP; Giesen-Crouse EM; Imbs JL
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):195-205. PubMed ID: 2954515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rabbit isolated arterially perfused intestinal segment preparation: a model for vascular dopamine receptors.
    Brown RA; O'Connor SE; Smith GW; Verity A
    J Pharmacol Methods; 1983 Apr; 9(2):137-45. PubMed ID: 6855251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
    Meltzer HY; Paul SM; Fang VS
    Psychopharmacology (Berl); 1977 Jan; 51(2):181-3. PubMed ID: 14352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacologic characteristics of renal dopaminergic receptors: therapeutic perspectives].
    Imbs JL; Schmidt M; Schwartz J
    J Pharmacol; 1983; 14 Suppl 3():5-27. PubMed ID: 6368999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulpiride isomers exhibit reversed stereospecificity for D-1 and D-2 dopamine receptors in the CNS.
    Leff SE; Chen A; Creese I
    Neuropharmacology; 1984 May; 23(5):589-90. PubMed ID: 6738827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of renal vascular dopamine receptors.
    Schmidt M; Imbs JL
    J Cardiovasc Pharmacol; 1980; 2(5):595-605. PubMed ID: 6157952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
    Meller E; Bordi F; Bohmaker K
    Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator effects of dopaminomimetics in the perfused rat kidney.
    Schmidt M; Imbs JL; Giesen EM; Schwartz J
    Eur J Pharmacol; 1982 Oct; 84(1-2):61-70. PubMed ID: 6183130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
    Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
    Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Flupenthixol increases slow-wave in rats: effect of dopamine receptor blockade.
    Fornal C; Wojcik WJ; Radulovacki M
    Neuropharmacology; 1982 Apr; 21(4):323-5. PubMed ID: 7201087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased striatal acetylcholine after 14 months cis-flupenthixol treatment in rats suggests functional supersensitivity of dopamine receptors.
    Murugaiah K; Mann S; Theodorou AE; Jenner P; Marsden CD
    Life Sci; 1982 Jul; 31(2):181-8. PubMed ID: 6889662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra.
    Pinnock RD
    Br J Pharmacol; 1984 Apr; 81(4):631-5. PubMed ID: 6144343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised dog.
    Hilditch A; Drew GM
    J Cardiovasc Pharmacol; 1984; 6(3):460-9. PubMed ID: 6202973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in sensitivity to neuroleptic blockade: medial forebrain bundle versus frontal cortex self-stimulation.
    Corbett D
    Behav Brain Res; 1990 Jan; 36(1-2):91-6. PubMed ID: 2302325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific antagonism by d-butaclamol of dopamine-induced relaxation of the isolated rabbit mesenteric artery.
    Brodde OE; Freistühler J; Meyer FJ
    J Cardiovasc Pharmacol; 1981; 3(4):828-37. PubMed ID: 6167812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible blockade of striatal dopamine receptors in vivo by a derivative of alpha-flupenthixol.
    Schuster DI; Holden WL; Narula AP; Murphy RB
    Eur J Pharmacol; 1982 Feb; 77(4):313-6. PubMed ID: 7060641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.